Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO | Zendy

Brian G. Poll | Zendy; Muhammad Umar Cheema | Zendy; Jennifer L. Pluznick | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO

Author(s) -

Brian G. Poll,

Muhammad Umar Cheema,

Jennifer L. Pluznick

Publication year - 2020

Publication title -

physiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.14

H-Index - 125

eISSN - 1548-9213

pISSN - 1548-9221

DOI - 10.1152/physiol.00004.2020

Subject(s) - gut microbiome , trimethylamine n oxide , gut flora , microbiome , metabolite , biology , microbial metabolism , trimethylamine , biochemistry , microbiology and biotechnology , bacteria , chemistry , bioinformatics , genetics

Shifts in the gut microbiome play a key role in blood pressure regulation, and changes in the production of gut microbial metabolites are likely to be a key mechanism. Known gut microbial metabolites include short-chain fatty acids, which can signal via G-protein-coupled receptors, and trimethylamine-N oxide. In this review, we provide an overview of gut microbial metabolites documented thus far to play a role in blood pressure regulation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research